Clinical Trial Update: Allergen Biocube Study Evaluating Efficacy and Safety of Nasapaque Nasal Solution in Adult Subjects With Allergic Rhinitis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating Nasapaque Nasal Solution for efficacy and safety in adults with seasonal allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Nasapaque Nasal Solution

Snippet

Sponsor: 3E Therapeutics Corporation | Conditions: Seasonal Allergic Rhinitis | Phase 1, Phase 2 | Status: COMPLETED